To determine if inactivation of PPP1R15A would have a net beneficial or detrimental effect in metabolic disease, we set out to model the later stages of type 2 diabetes wherein beta-cell mass falls in the face of sustained insulin resistance27. Here, INS is linked to type 2 diabetes mellitus.